096530

SEEGENE is a biotechnology company specializing in molecular diagnostics, utilizing syndromic real-time PCR technology to detect multiple pathogens simultaneously from human and animal samples. The company develops and sells diagnostic reagents, automated diagnostic equipment, and data analysis software. Its product portfolio includes the Allplex series of multiplex PCR kits, the CURECA automated sample preparation system, and the STARlet-AIOS all-in-one PCR system. SEEGENE serves hospitals, clinical laboratories, and research institutions globally, with a presence in Europe, North America, and Asia through local subsidiaries and distributors. The company operates a technology-sharing initiative to collaborate with international partners on localized diagnostic solutions. Founded in 2000, SEEGENE holds patents in high-multiplex PCR technologies and maintains a global sales network.

Summarised from the company's own disclosures, fiscal year ended May 2026

Industry Diagnostics & Research Homepage kr.seegene.com
Sector Healthcare IR page —
Tags
molecular diagnostics, pcr testing, infectious disease diagnostics, oncology diagnostics, automated laboratory systems, genetic testing, multiplex assays, clinical laboratory equipment, Allplex, CURECA, STARlet-AIOS, STAgora, SGDDS, SG OneSystem, Seegene viewer, SG STATS, DPO, TOCE, MuDT, 3Ct, STST, Werfen, Hylabs, Microsoft, Springer Nature
Press page —

Metrics

Valuation  
Market cap —
Market cap (USD) —
P/E —
PEG —
P/BV —
P/S —
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 4.8%
ROI 4.8%
ROIC 2.9%
Profit margin 10.2%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -35.8%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock —
Diluting (TTM) —
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) —
Quality score 27.3%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 474.232B 414.252B 367.375B 853.561B 1.371T 1.125T 121.953B 102.265B 87.663B 73.694B 65.137B 64.411B 58.993B
Net profit 48.275B -20.337B 669.012M 182.139B 536.559B 502.281B 26.672B 10.728B 3.997B 7.123B 6.774B 9.141B 9.573B
Free cash flow 111.977B 45.397B 69.778B 255.746B 272.368B 209.129B 23.076B 11.079B 14.51B 10.658B -6.317B 4.138B -4.133B

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (KRW) 54.9B 52.5B 46.3B 52.2B 307B 340B 112B 89.8B 93.6B 105B
↳ YoY growth -3.2% -4.3% -11.9% +12.8% +489.0% +10.8% -67.1% -20.0% +4.3% +11.8%
↳ 5y CAGR -1.0% +0.6% +40.2% +44.1% +16.4% +14.2% +12.4% -19.4%
Borrowings, current (KRW) 678M 6.96B 8.43B 6.42B 37.9B 40.8B 80.5B 75.9B 75.8B 76.1B
Borrowings, non-current (KRW) 44.6B 12.8B 1.81B 1.72B 44.4B 43.1B 2.17B 1.42B 763M 232M
Bonds payable (KRW) 44.6B 12B — — — — — — — —
Lease liabilities (KRW) — — — 6.96B 20.7B 75.1B 76.5B 64.5B 67.1B 53.6B
Cash and deposits (KRW) 49.8B 27.8B 32.6B 49.1B 308B 432B 521B 190B 260B 226B
Intangible assets (KRW) 22.4B 23.4B 6B 6.67B 6.71B 11.5B 24.4B 27.4B 33B 28.6B
Right-of-use assets (KRW) — — — 7.38B 22.4B 79.2B 78.1B 65.2B 56.2B 47.3B
Net debt (borrowings + leases - cash) (KRW) -4.46B -8.01B -22.4B -34B -205B -273B -362B -48.6B -116B -95.6B
Cash flow detail
Operating cash flow (KRW) 16.6B 19.3B 14B 27.1B 383B 334B 319B 94.9B 85.4B 149B
Purchases of property, plant and equipment (KRW) -5.9B -4.83B -2.93B -4.07B -174B -61.7B -63.3B -25.2B -40B -37.4B
Purchases of intangible assets (KRW) -4.82B -10.7B -1.03B -721M -1.24B -4.45B -9.19B -6.73B -3.63B -3.11B
Dividends paid (cash effect) (KRW) — — — — -2.6B -70B -51.1B -38.1B -36.9B -36.9B
Share buybacks (cash effect) (KRW) 0.00 -2.98B — — — -29.4B -70.4B -89.9B -2.45B -4.13B
Interest paid (cash effect) (KRW) -511M -348M -357M -386M -1.61B -1.76B -2.88B -3.79B -3.42B -4.4B
Income taxes paid (cash effect) (KRW) -2.64B -2.95B 165M 3.31B -10.3B -227B -162B -2.69B -3.07B 10.5B
Free cash flow (OCF - PPE - intangibles) (KRW) 5.84B 3.79B 10B 22.4B 208B 268B 247B 63.1B 41.8B 109B
Income detail
Research and development expense (KRW) — — — — — — 94.7B 72.7B 69.4B 66.3B
Total comprehensive income (KRW) 6.73B 2.76B 10.3B 26.6B 496B 536B 188B 5.53B -16.6B 59.5B
Comprehensive income to owners (KRW) 6.68B 2.71B 10.3B 26.5B 495B 535B 188B 5.34B -16.7B 59.4B
Reported Nov 14, 2017 Apr 2, 2018 Nov 14, 2019 Mar 30, 2020 Mar 18, 2021 Mar 14, 2024 May 15, 2026 Mar 19, 2026 May 15, 2026 Mar 19, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

현금ㆍ현물배당결정 (분기배당) Bull 1 Bear 0 Capital return
주요사항보고서(자기주식처분결정) Bull 0 Bear 0 Routine

Prompts

SEEGENE (ticker 096530), listed in South Korea.

ETFs Holding SEEGENE

ETF Weight in ETF Shares Market value As of
AVEE 0.06% 4,265 $ 77.024K Nov 16, 2026
DFEV 0.02% 24,114 $ 454.93K Nov 12, 2026
DEXC 0.01% 2,005 $ 37.826K Nov 12, 2026
DFEM 0.01% 52,717 $ 994.548K Nov 12, 2026
DFSE 0.01% 3,117 $ 58.805K Nov 12, 2026
AVEM 0.01% 81,459 $ 1.471M Nov 16, 2026
AVSE 0.01% 882 $ 15.929K Nov 16, 2026
DFAE 0.01% 32,257 $ 608.554K Nov 12, 2026
DFAX 0.00% 30,951 $ 583.915K Nov 12, 2026
AVXC 0.00% 109 $ 1,968.50 Nov 16, 2026